Shih Chun Ho
Direktor/Vorstandsmitglied bei TRADE-VAN INFORMATION SERVICES CO.
Profil
Shih Chun Ho is currently the Chairman at Asia We Co., Ltd.
He also holds the position of Independent Director at Collins Co., Ltd., Director at Trade-Van Information Services Co., Independent Director at Super Dragon Technology Co., Ltd., Independent Director at Center Laboratories, Inc., Director at Allied Biotech Corp., Director at Forcera Materials Co. Ltd., Director at Ever Supreme Bio Technology Co., Ltd., Director at Luo Lih-Fen Holding Co., Ltd., and Member-Supervisory Board at Taiwan Lu.
Ti Investment Co. Ltd.
and IBT II Venture Capital Co., Ltd.
In the past, Mr. Ho served as Chairman at National Taiwan University and Independent Director at TPG Biologics, Inc. Mr. Ho completed his graduate degree at Golden Gate University and National Taiwan University.
He also holds an undergraduate degree from Fu Jen Catholic University.
Aktive Positionen von Shih Chun Ho
Unternehmen | Position | Beginn |
---|---|---|
TRADE-VAN INFORMATION SERVICES CO. | Direktor/Vorstandsmitglied | 26.07.1996 |
CENTER LABORATORIES, INC. | Direktor/Vorstandsmitglied | 14.06.2010 |
COLLINS CO., LTD. | Direktor/Vorstandsmitglied | 10.06.2016 |
ALLIED BIOTECH CORPORATION | Direktor/Vorstandsmitglied | 01.05.2016 |
EVER SUPREME BIO TECHNOLOGY CO., LTD | Direktor/Vorstandsmitglied | 26.06.2018 |
LUO LIH-FEN HOLDING CO., LTD. | Direktor/Vorstandsmitglied | 30.11.2017 |
SUPER DRAGON TECHNOLOGY CO., LTD | Direktor/Vorstandsmitglied | 18.06.2019 |
FORCERA MATERIALS CO., LTD. | Direktor/Vorstandsmitglied | 01.02.2023 |
IBT II Venture Capital Co., Ltd.
IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Direktor/Vorstandsmitglied | - |
░░░░ ░░ ░░░░ ░░░░ | ░░░░░░░░░░░░ | - |
░░░░░░ ░░ ░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Shih Chun Ho
Unternehmen | Position | Ende |
---|---|---|
░░░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░ | - |
░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Shih Chun Ho
National Taiwan University | Graduate Degree |
Golden Gate University | Graduate Degree |
Fu Jen Catholic University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 8 |
---|---|
TRADE-VAN INFORMATION SERVICES CO. | Technology Services |
CENTER LABORATORIES, INC. | Health Technology |
COLLINS CO., LTD. | Distribution Services |
ALLIED BIOTECH CORPORATION | Consumer Non-Durables |
EVER SUPREME BIO TECHNOLOGY CO., LTD | Health Technology |
LUO LIH-FEN HOLDING CO., LTD. | Consumer Non-Durables |
SUPER DRAGON TECHNOLOGY CO., LTD | Industrial Services |
FORCERA MATERIALS CO., LTD. | Electronic Technology |
Private Unternehmen | 4 |
---|---|
IBT II Venture Capital Co., Ltd.
IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Finance |
Asia We Co., Ltd. | |
Taiwan Lu Ti Investment Co. Ltd.
Taiwan Lu Ti Investment Co. Ltd. Financial ConglomeratesFinance Taiwan Lu Ti Investment Co. Ltd. is an investment company based in Taipei, Taiwan. | Finance |
TPG Biologics, Inc.
TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |